1. Cell Cycle/DNA Damage
  2. DNA/RNA Synthesis
  3. SMN2 modulator-1

SMN2 modulator-1 is a brain-penetrant survival motor neuron (SMN) modulator. SMN2 modulator-1 post-translationally stabilizes SMN protein and increases SMN protein levels independent of SMN2 transcription. SMN2 modulator-1 can be used for the research of spinal muscular atrophy[1].

For research use only. We do not sell to patients.

SMN2 modulator-1

SMN2 modulator-1 Chemical Structure

CAS No. : 1537150-15-4

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All DNA/RNA Synthesis Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SMN2 modulator-1 is a brain-penetrant survival motor neuron (SMN) modulator. SMN2 modulator-1 post-translationally stabilizes SMN protein and increases SMN protein levels independent of SMN2 transcription. SMN2 modulator-1 can be used for the research of spinal muscular atrophy[1].

Cellular Effect
Cell Line Type Value Description References
HEK293 EC50
0.29 μM
Compound: 27
Stabilization of human SMN protein expressed in HEK293 cells expressing SMN2 promoter after 24 hrs by luciferase reporter gene assay
Stabilization of human SMN protein expressed in HEK293 cells expressing SMN2 promoter after 24 hrs by luciferase reporter gene assay
[PMID: 28481536]
In Vitro

SMN2 modulator-1 (Compound 27) (0.29-30 μM; 24 h) potently activates SMN2 expression in SMN2 reporter cells with an EC50 of 0.29 μM, reaching 190% of control activity[1].
SMN2 modulator-1 (0.4-10 μM; 48 h) increases SMN protein levels in GM003813T SMA patient fibroblasts by approximately 2-fold at a 2 μM 48 h treatment, in a dose-dependent manner[1].
SMN2 modulator-1 has a kinetic solubility of 31 μM at pH 7.4, a mouse liver microsome half-life of 39 min, human liver microsome half-life of >120 min, and mouse plasma half-life of 326 min[1].
SMN2 modulator-1 (1-30 μM; 30 min-8 h) does not inhibit the proteasome or autophagy in HEK293 cells, nor does it inhibit HPV-16 E6 mediated p53 degradation in vitro, indicating its SMN-stabilizing effect is not due to global protein degradation inhibition[1].
SMN2 modulator-1 shows adequate intestinal permeability in the Caco-2 cell model, with an apical-to-basal Papp of 15 × 10-6 cm/s[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: hTERT-immortalized SMA patient fibroblasts (GM003813T)
Concentration: 0.4 μM; 2 μM; 10 μM
Incubation Time: 48 h
Result: Produced a dose-dependent increase in SMN protein levels.
Increased SMN protein levels to approximately 2-fold relative to DMSO control at 2 μM.
Parmacokinetics
Species Dose Route Cmax AUC0-∞ (Plasma) Tmax (Plasma) T1/2 (Plasma) Cmax (Brain) AUC0-∞ (Brain) Tmax (Brain) T1/2 (Brain)
Mice[1] 20 mg/kg i.p. 7660 ng/mL 34291 ng·h/mL 0.5 h 2.2 h 13500 ng/mL 51310 ng·h/mL 0.5 h 1.9 h
Mice[1] 20 mg/kg p.o. 286 ng/mL 1641 ng·h/mL 0.5 h 3.4 h 446 ng/mL 2223 ng·h/mL 0.5 h 2.8 h
In Vivo

SMN2 modulator-1 (Compound 27) (20 mg/kg; i.p. or p.o.; single dose) achieves high plasma and brain exposure with favorable brain-to-plasma ratios after single intraperitoneal dosing, while oral dosing at the same dose results in moderate, lower exposure in adult mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: mice (adult)[1]
Dosage: 20 mg/kg
Administration: i.p. or p.o.; single dose
Result: Reached a plasma Cmax of 7660 ng/mL, plasma AUC0-24h of 34291 ng·h/mL, plasma Tmax of 0.5 h, plasma T1/2 of 2.2 h, brain Cmax of 13500 ng/mL, brain AUC0-24h of 51310 ng·h/mL, brain Tmax of 0.5 h, brain T1/2 of 1.9 h, and a brain-to-plasma ratio of 1.5:1 following intraperitoneal dosing.
Reached a plasma Cmax of 286 ng/mL, plasma AUC0-24h of 1641 ng·h/mL, plasma Tmax of 0.5 h, plasma T1/2 of 3.4 h, brain Cmax of 446 ng/mL, brain AUC0-24h of 2223 ng·h/mL, brain Tmax of 0.5 h, brain T1/2 of 2.8 h, and a brain-to-plasma ratio of 1.4:1 following oral dosing.
Molecular Weight

326.77

Formula

C14H12ClFN2O2S

CAS No.
SMILES

O=C(C1=CC=C(C(Cl)=C1)F)NC2=NC=C(C3(CCC3)O)S2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SMN2 modulator-1
Cat. No.:
HY-124640
Quantity:
MCE Japan Authorized Agent: